4//SEC Filing
Zelnick Kaufman Beth 4
Accession 0001213900-25-087014
CIK 0001410098other
Filed
Sep 10, 8:00 PM ET
Accepted
Sep 11, 9:45 PM ET
Size
10.5 KB
Accession
0001213900-25-087014
Insider Transaction Report
Form 4
CorMedix Inc.CRMD
Zelnick Kaufman Beth
Chief Legal Officer
Transactions
- Sale
Common Stock
2025-09-09$13.41/sh−49,600$665,136→ 180,818 total - Exercise/Conversion
Stock Option (Right to Buy Common Stock)
2025-09-09−50,000→ 150,000 totalExercise: $3.30Exp: 2033-12-11→ Common Stock (50,000 underlying) - Exercise/Conversion
Common Stock
2025-09-09$3.30/sh+50,000$165,000→ 230,418 total - Sale
Common Stock
2025-09-09$12.82/sh−400$5,128→ 180,418 total
Footnotes (2)
- [F1]This transaction was executed in multiple trades at prices ranging from $12.83 to $13.82. The price reported in Column 4 is a weighted average price. The reporting person hereby undertakes to provide upon request to the SEC staff, the Issuer or a security holder of the Issuer full information regarding the number of shares and prices at which the transactions were effected.
- [F2]These options were granted on 12/12/2023. These options vest over four years in four equal installments on the first four anniversaries of the grant date, subject to continued employment through the applicable vesting date.
Documents
Issuer
CorMedix Inc.
CIK 0001410098
Entity typeother
Related Parties
1- filerCIK 0002004480
Filing Metadata
- Form type
- 4
- Filed
- Sep 10, 8:00 PM ET
- Accepted
- Sep 11, 9:45 PM ET
- Size
- 10.5 KB